Proline residues in the HIV-1 NH2-terminal capsid domain: Structure determinants for proper core assembly and subsequent steps of early replication

Virology

Volumn 268, Issue 2, 2000, Pages 294-307

  Fitzon, Tanja ^a   Leschonsky, Bernd ^a   Bieler, Kurt ^a   Paulus, Christina ^a   Schröder, Josef ^a   Wolf, Hans ^a   Wagner, Ralf ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Assembly; Capsid; Core; HIV 1; Replication

Indexed keywords

COMPLEMENTARY DNA; CYCLOPHILIN A; PROLINE; VIRUS DNA;

AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; GENE MUTATION; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN STABILITY; PROTEIN STRUCTURE; PROTEIN TERTIARY STRUCTURE; VIRUS CAPSID; VIRUS CORE; VIRUS PARTICLE; VIRUS REPLICATION;

ANIMALIA; DNA VIRUSES; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MIRIDAE; RNA VIRUSES;

EID: 0034653538     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.0178     Document Type: Article

References (68)

1. Ackerson B., Rey O., Canon J., Krogstad P. Cells with high cyclophilin A content support replication of human immunodeficiency virus type 1 Gag mutants with decreased ability to incorporate cyclophilin A. J. Virol. 72:1998;303-308.
2. Amadori A., Zamarchi R., Veronese M. L., Panozzo M., Barelli A., Borri A., Sironi M., Colotta F., Mantovani A., Chieco Bianchi L. B cell activation during HIV-1 infection. II. Cell-to-cell interactions and cytokine requirement. J. Immunol. 146:1991;57-62.
3. Bess J. W. Jr., Gorelick R. J., Bosche W. J., Henderson L. E., Arthur L. O. Microvesicles are a source of contaminating cellular proteins found in purified HIV-1 preparations. Virology. 230:1997;134-144.
4. Billich A., Hammerschmid F., Peichl P., Wenger R., Zenke G., Quesniaux V., Rosenwirth B. Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus (HIV) type 1: Interference with HIV protein-cyclophilin A interactions. J. Virol. 69:1995;2451-2461.
5. Braaten D., Franke E. K., Luban J. Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription. J. Virol. 70:1996;3551-3560.
6. Brown P. O., Bowerman B., Varmus H. E., Bishop J. M. Correct integration of retroviral DNA in vitro. Cell. 49:1987;347-356.
7. Brown P. O., Bowerman B., Varmus H. E., Bishop J. M. Retroviral integration: Structure of the initial covalent product and its precursor, and a role for the viral IN protein. Proc. Natl. Acad. Sci. USA. 86:1989;2525-2529.
8. Camaur D., Trono D. Characterization of human immunodeficiency virus type 1 Vif particle incorporation. J. Virol. 70:1996;6106-6111.
9. Chazal N., Carriere C., Gay B., Boulanger P. Phenotypic characterization of insertion mutants of the human immunodeficiency virus type 1 Gag precursor expressed in recombinant baculovirus-infected cells. J. Virol. 68:1994;111-122.
10. Chen C., Okayama H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7:1987;2745-2752.
11. Dorfman T., Bukovsky A., Ohagen A., Hoglund S., Gottlinger H. G. Functional domains of the capsid protein of human immunodeficiency virus type 1. J. Virol. 68:1994a;8180-8187.
12. Dorfman T., Mammano F., Haseltine W. A., Gottlinger H. G. Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein. J. Virol. 68:1994b;1689-1696.
13. Fischer G., Wittmann Liebold B., Lang K., Kiefhaber T., Schmid F. X. Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins. Nature. 337:1989;476-478.
14. Franke E. K., Yuan H. E., Luban J. Specific incorporation of cyclophilin A into HIV-1 virions. Nature. 372:1994;359-362.
15. Freed E. O., Martin M. A. Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix. J. Virol. 69:1995;1984-1989.
16. Gamble R. T., Vajdos F. F., Yoo S., Houseweart M., Sundquist W. J., Hill P. C. Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid. Cell. 87:1996;1285-1294.
17. Gamble T. R., Yoo S., Vajdos F. F., von Schwedler U. K., Worthylake D. K., Wang H., McCutcheon J. P., Sundquist W. I., Hill C. P. Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein. Science. 278:1997;849-853.
18. Gelderblom H. R. Assembly and morphology of HIV: Potential effect of structure on viral function. AIDS. 5:1991;617-637.
19. Gething M. J., Sambrook J. Protein folding in the cell. Nature. 355:1992;33-45.
20. Gheysen D., Jacobs E., de Foresta F., Thiriart C., Francotte M., Thines D., De Wilde M. Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells. Cell. 59:1989;103-112.
21. Gitti R. K., Lee B. M., Walker J., Summers M. F., Yoo S., Sundquist W. I. Structure of the amino-terminal core domain of the HIV-1 capsid protein. Science. 273:1996;231-235.
22. Gottlinger H. G., Sodroski J. G., Haseltine W. A. Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA. 86:1989;5781-5785.
23. Gottlinger H. G., Dorfman T., Cohen E. A., Haseltine W. A. Vpu protein of human immunodeficiency virus type 1 enhances the release of capsids produced by gag gene constructs of widely divergent retroviruses. Proc. Natl. Acad. Sci. USA. 90:1993;7381-7385.
24. Gross I., Hohenberg H., Huckhagel C., Krausslich H. G. N-terminal extension of human immunodeficiency virus capsid protein converts the in vitro assembly phenotype from tubular to spherical particles. J. Virol. 72:1998;4798-4810.
25. Haffar O., Garrigues J., Travis B., Moran P., Zarling J., Hu S. L. Human immunodeficiency virus-like, nonreplicating, gag-env particles assemble in a recombinant vaccinia virus expression system. J. Virol. 64:1990;2653-2659.
26. Henderson L. E., Bowers M. A., Sowder R. C., Serabyn S. A., Johnson D. G., Bess J. W. Jr., Arthur L. O., Bryant D. K., Fenselau C. Gag proteins of the highly replicative MN strain of human immunodeficiency virus type 1: Posttranslational modifications, proteolytic processings, and complete amino acid sequences. J. Virol. 66:1992;1856-1865.
27. Hockley D. J., Nermut M. V., Grief C., Jowett J. B., Jones I. M. Comparative morphology of Gag protein structures produced by mutants of the gag gene of human immunodeficiency virus type 1. J. Gen. Virol. 75:1994;2985-2997.
28. Hoglund S., Ohagen A., Lawrence K., Gabuzda D. Role of vif during packing of the core of HIV-1. Virology. 201:1994;349-355.
29. Huang M., Martin M. A. Incorporation of Pr160(gag-pol) into virus particles requires the presence of both the major homology region and adjacent C-terminal capsid sequences within the Gag-Pol polyprotein. J. Virol. 71:1997;4472-4478.
30. Jacks T., Power M. D., Masiarz F. R., Luciw P. A., Barr P. J., Varmus H. E. Characterization of ribosomal frameshifting in HIV-1 gag-pol expression. Nature. 331:1988;280-283.
31. Jones T. A., Blaug G., Hansen M., Barklis E. Assembly of gag-β-galactosidase proteins into retrovirus particles. J. Virol. 64:1990;2265-2279.
32. Kappes J. C., Morrow C. D., Lee S. W., Jameson B. A., Kent S. B., Hood L. E., Shaw G. M., Hahn B. H. Identification of a novel retroviral gene unique to human immunodeficiency virus type 2 and simian immunodeficiency virus SIVMAC. J. Virol. 62:1988;3501-3505.
33. Kimpton J., Emerman M. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated β-galactosidase gene. J. Virol. 66:1992;2232-2239.
34. Klimkait T., Strebel K., Hoggan M. D., Martin M. A., Orenstein J. M. The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release. J. Virol. 64:1990;621-629.
35. Kong L. B., An D., Ackerson B., Canon J., Rey O., Chen I. S., Krogstad P., Stewart P. L. Cryoelectron microscopic examination of human immunodeficiency virus type 1 virions with mutations in the cyclophilin A binding loop. J. Virol. 72:1998;4403-4407.
36. Krausslich H. G., Facke M., Heuser A. M., Konvalinka J., Zentgraf H. The spacer peptide between human immunodeficiency virus capsid and nucleocapsid proteins is essential for ordered assembly and viral infectivity. J. Virol. 69:1995;3407-3419.
37. Luban J., Bossolt K. L., Franke E. K., Kalpana G. V., Goff S. P. Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B. Cell. 73:1993;1067-1078.
38. Mammano F., Ohagen A., Hoglund S., Gottlinger H. G. Role of the major homology region of human immunodeficiency virus type 1 in virion morphogenesis. J. Virol. 68:1994;4927-4936.
39. Mammano F., Kondo E., Sodroski J., Bukovsky A., Gottlinger H. G. Rescue of human immunodeficiency virus type 1 matrix protein mutants by envelope glycoproteins with short cytoplasmic domains. J. Virol. 69:1995;3824-3830.
40. Mergener K., Facke M., Welker R., Brinkmann V., Gelderblom H. R., Krausslich H. G. Analysis of HIV particle formation using transient expression of subviral constructs in mammalian cells. Virology. 186:1992;25-39.
41. Mervis R. J., Ahmad N., Lillehoj E. P., Raum M. G., Salazar F. H., Chan H. W., Venkatesan S. The gag gene products of human immunodeficiency virus type 1: Alignment within the gag open reading frame, identification of posttranslational modifications, and evidence for alternative gag precursors. J. Virol. 62:1988;3993-4002.
42. Momany C., Kovari L. C., Prongay A. J., Keller W., Gitti R. K., Lee B. M., Gorbalenya A. E., Tong L., McClure J., Ehrlich L. S., Summers M. F., Carter C., Rossmann M. G. Crystal structure of dimeric HIV-1 capsid protein. Nat. Struct. Biol. 3:1996;763-770.
43. Partin K., Krausslich H. G., Ehrlich L., Wimmer E., Carter C. Mutational analysis of a native substrate of the human immunodeficiency virus type 1 proteinase. J. Virol. 64:1990;3938-3947.
44. Pauza C. D., Trivedi P., McKechnie T. S., Richman D. D., Graziano F. M. 2-LTR circular viral DNA as a marker for human immunodeficiency virus type 1 infection in vivo. Virology. 205:1994;470-478.
45. Pettit S. C., Moody M. D., Wehbie R. S., Kaplan A. H., Nantermet P. V., Klein C. A., Swanstrom R. The p2 domain of human immunodeficiency virus type 1 Gag regulates sequential proteolytic processing and is required to produce fully infectious virions. J. Virol. 68:1994;8017-8027.
46. Ratner L., Haseltine W., Patarca R., Livak K. J., Starcich B., Josephs S. F., Doran E. R., Rafalski J. A., Whitehorn E. A., Baumeister K. Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature. 313:1985;277-284.
47. Reicin A. S., Ohagen A., Yin L., Hoglund S., Goff S. P. The role of Gag in human immunodeficiency virus type 1 virion morphogenesis and early steps of viral life cycle. J. Virol. 70:1996;8645-8652.
48. Reynolds E. S. The use of citrate high pH as an electronopage stain in electron microscopy. J. Cell Biol. 17:1963;208-212.
49. Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
50. Smith A. J., Cho M. I., Hammarskjold M. L., Rekosh D. Human immunodeficiency virus type 1 Pr55gag and Pr160gag-pol expressed from a simian virus 40 late replacement vector are efficiently processed and assembled into viruslike particles. J. Virol. 64:1990;2743-2750.
51. Steinkasserer A., Harrison R., Billich A., Hammerschmid F., Werner G., Wolff B., Peichl P., Palfi G., Schnitzel W., Mlynar E. Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus type 1 (HIV-1): Interference with early and late events in HIV-1 replication. J. Virol. 69:1995;814-824.
52. Strambio de Castillia C., Hunter E. Mutational analysis of the major homology region of Mason-Pfizer monkey virus by use of saturation mutagenesis. J. Virol. 66:1992;7021-7032.
53. Thali M., Furman C., Ho D. D., Robinson J., Tilley S., Pinter A., Sodroski J. Discontinuous, conserved neutralization epitopes overlapping the CD4-binding region of human immunodeficiency virus type 1 gp120 envelope glycoprotein. J. Virol. 66:1992;5635-5641.
54. Thali M., Bukovsky A., Kondo E., Rosenwirth B., Walsh C. T., Sodroski J., Gottlinger H. G. Functional association of cyclophilin A with HIV-1 virions. Nature. 372:1994;363-365.
55. Trono D., Feinberg M. B., Baltimore D. HIV-1 Gag mutants can dominantly interfere with the replication of the wild-type virus. Cell. 59:1989;113-120.
56. von Poblotzki A., Wagner R., Niedrig M., Wanner G., Wolf H., Modrow S. Identification of a region in the Pr55gag-polyprotein essential for HIV-1 particle formation. Virology. 193:1993;981-985.
57. von Schwedler U., Song J., Aiken C., Trono D. Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells. J. Virol. 67:1993;4945-4955.
58. von Schwedler U. K., Stemmler T. L., Klishko V. Y., Li S., Albertine K. H., Davis D. R., Sundquist W. I. Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly. EMBO J. 17:1998;1555-1568.
59. Wagner R., Fliessbach H., Wanner G., Motz M., Niedrig M., Deby G., von Brunn A., Wolf H. Studies on processing, particle formation, and immunogenicity of the HIV-1 gag gene product: A possible component of a HIV vaccine. Arch. Virol. 127:1992;117-137.
60. Wagner R., Boltz T., Deml L., Modrow S., Wolf H. Induction of cytolytic T lymphocytes directed towards the V3 loop of the human immunodeficiency virus type 1 external glycoprotein gp120 by p55gag/V3 chimeric vaccinia viruses. J. Gen. Virol. 74:1993;1261-1269.
61. Wagner R., Deml L., Fliessbach H., Wanner G., Wolf H. Assembly and extracellular release of chimeric HIV-1 Pr55gag retrovirus-like particles. Virology. 200:1994;162-175.
62. Wang C. T., Barklis E. Assembly, processing, and infectivity of human immunodeficiency virus type 1 gag mutants. J. Virol. 67:1993;4264-4273.
63. Wang C. T., Stegeman Olsen J., Zhang Y., Barklis E. Assembly of HIV GAG-B-galactosidase fusion proteins into virus particles. Virology. 200:1994;524-534.
64. Weldon R. A. Jr., Erdie C. R., Oliver M. G., Wills J. W. Incorporation of chimeric gag protein into retroviral particles. J. Virol. 64:1990;4169-4179.
65. Wiegers K., Rutter G., Kottler H., Tessmer U., Hohenberg H., Krausslich H. G. Sequential steps in human immunodeficiency virus particle maturation revealed by alterations of individual Gag polyprotein cleavage sites. J. Virol. 72:1998;2846-2854.
66. Wiegers K., Rutter G., Schubert U., Grattinger M., Krausslich H. G. Cyclophilin A incorporation is not required for human immunodeficiency virus type 1 particle maturation and does not destabilize the mature capsid. Virology. 257:1999;261-274.
67. Wills J. W., Craven R. C. Form, function, and use of retroviral gag proteins. AIDS. 5:1991;639-654.
68. Yu X., Yuan X., Matsuda Z., Lee T. H., Essex M. The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions. J. Virol. 66:1992;4966-4971.